drugset / Trial / NCT00162071
A Phase II Optimization Study of BMS068645 and Sestamibi Planar Imaging
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
The primary purpose of this study is to determine the optimal time for myocardial perfusion imaging with Technetium Tc99m Sestamibi following the administration of BMS068645. The safety of BMS068645 will also be studied.
Timeline
- Start
- 2005-07
- Primary completion
- 2006-03
- Completion
- —
Outcome
Outcome not reported
Stopped: “Sponsor decided not to continue with the development program”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Apadenoson | Small molecule | — | — |